SCHEMBL3027896

SCHEMBL3027896

CCOC(=O)C(NC(=O)CC)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MGAM O43451 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ SI P14410 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ SOAT1 P35610 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.36
▸ CAD P27708 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL964570 0.83 LMNA (0.50) L3MBTL1ALDH1A1LMNAHSD17B10MGAM
SCHEMBL9917049 0.83 CYP2C9 (0.50) CYP2C9ALDH1A1LMNAKMT2APOLB
SCHEMBL3032954 0.78 LMNA (0.43) L3MBTL1ALDH1A1LMNAHSD17B10MGAM
SCHEMBL3023544 0.78 HCRTR2 (0.47) ALDH1A1LMNAGAAKMT2APOLB
SCHEMBL12160531 0.77 TGFBR1 (0.42) L3MBTL1ALDH1A1LMNAHSD17B10MGAM
SCHEMBL10530552 0.77 PSMB5 (0.46) CYP2C9L3MBTL1ALDH1A1LMNAMGAM
SCHEMBL14786634 0.77 ALDH1A1 (0.44) CYP2C9L3MBTL1ALDH1A1LMNAHSD17B10
SCHEMBL21393378 0.77 ALDH1A1 (0.44) CYP2C9L3MBTL1ALDH1A1LMNAHSD17B10
SCHEMBL31501278 0.77 CYP2C9 (0.45) CYP2C9ALDH1A1LMNAGAAKMT2A
SCHEMBL8992064 0.76 LMNA (0.41) CYP2C9ALDH1A1LMNAHSD17B10CAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119708525-A Superfine grain tungsten-based composite material and preparation method thereof 江西澳科新材料科技股份有限公司 2025-03-28 — — CN claimed
CN-119708525-A Superfine grain tungsten-based composite material and preparation method thereof 江西澳科新材料科技股份有限公司 2025-03-28 — — CN disclosed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 — — US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 — — US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 — — EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 CYP2C9 720/4885L3MBTL1 1657/4885ALDH1A1 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback